NuvaRing Lawsuit Filed by Wright & Schulte LLC After Ohio Woman Allegedly Suffered Life-Threatening NuvaRing Blood Clots, Including Bilateral Pulmonary Emboli

NuvaRing Lawsuit Filed by Wright & Schulte LLC on behalf of Ohio Woman Allegedly Who Suffered Life-Threatening Blood Clots, is a Potential Tag-Along Action in Federal NuvaRing Multidistrict Litigation, Where More than 1,500 NuvaRing Blood Clot Lawsuits Involving Similar Allegations Have Been Filed

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
If you or someone you love suffered a blood clot, pulmonary embolism, deep vein thrombosis, heart attack, stroke or sudden death while using #NuvaRing, visit yourlegalhelp.com, or call  1-800-399-0795

If you or someone you love suffered a blood clot, pulmonary embolism, deep vein thrombosis, heart attack, stroke or sudden death while using #NuvaRing, visit yourlegalhelp.com, or call 1-800-399-0795

If you or someone you love suffered a blood clot, pulmonary embolism, deep vein thrombosis, heart attack, stroke or sudden death while using NuvaRing, visit yourlegalhelp.com, or call 1-800-399-0795

Columbus, OH (PRWEB) November 13, 2013

A woman from Dayton, Ohio is being represented by Wright & Schulte LLC in a NuvaRing lawsuit, after she suffered life-threatening blood clots, including bilateral pulmonary emboli and deep vein thrombosis, allegedly due to her use of the NuvaRing vaginal birth control ring. Her NuvaRing blood clot lawsuit complaint, which was filed on September 24, 2013 in U.S. District Court, Southern District of Ohio, claims that NuvaRing poses a substantially higher risk of blood clots, including deep vein thrombosis and pulmonary embolism, compared to other hormonal forms of birth control. (Case: 3:13-cv-00328-WHR)

According to her NuvaRing lawsuit, the Plaintiff began using the device, which is the first and only vaginal birth control ring available on the market, in March or April of 2012. On April 22, 2012, when she was only 22 years old, the young woman began experiencing shortness of breath and chest pain. Upon admission to the hospital, a CT scan revealed that she had developed massive bilateral emboli, including a saddle embolus. She was immediately placed on a heparin IV, and further testing revealed that she was also suffering from a deep vein thrombosis in her right leg. As stated in the NuvaRing blood clot lawsuit, Plaintiff was placed on Coumadin, Fragmin, and Lovenox, and remained in the hospital for 15 days due to the injuries she allegedly sustained from NuvaRing.

NuvaRing Lawsuit Contends Increased Risk for Serious Blood Clots
The NuvaRing lawsuit alleges that the vaginal ring releases higher amounts of hormones than other hormonal forms of birth control, which increases the risk for serious blood clots that have the potential to cause heart attacks, stroke, and even death. The Plaintiff also accuses Merck & Co. and other Defendants named in the complaint of failing to provide adequate warnings regarding the risk of serious NuvaRing blood clots, including deep vein thrombosis and pulmonary embolism, compared to oral contraceptives.

According to the NuvaRing blood clot lawsuit complaint, though the NuvaRing lawsuit was filed in the Southern District of Ohio, it is a potential tag-along action and should be transferred to the federal NuvaRing multidistrict litigation (MDL) currently underway in U.S. District Court, Eastern District of Missouri, where more than 1,500 complaints involving similar allegations of NuvaRing blood clots are currently pending. In an Order dated October 8th, Judge Rodney W. Sippel, who is overseeing the federal NuvaRing litigation, postponed its first bellwether trial until April 2014, and ordered that all discovery, motions and rulings be stayed in the federal NuvaRing lawsuits until December 2013. Judge Sippel’s Order also directed attorneys for plaintiffs to conduct a census “of all claims they are pursuing, whether they are pending in federal court, state court or have not yet been filed.” According to the Order, plaintiffs’ attorneys were required to provide the information sought by the Court no later than October 28, 2013. (In re NuvaRing Products Liability Litigation, MDL 1964)

Filing a Nuvaring Lawsuit Or NuvaRing Blood Clot Lawsuit
Wright & Schulte LLC continues to offer free NuvaRing lawsuit evaluations to alleged victims of NuvaRing side effects. If you or someone you love suffered a blood clot, pulmonary embolism, deep vein thrombosis, heart attack, stroke or sudden death while using NuvaRing, please visit yourlegalhelp.com, or call toll-FREE 1-800-399-0795 to learn more about your options for legal recourse or filing a NuvaRing Lawsuit.

Keep up with NurvaRing lawsuit news and other information by liking Wright & Schulte LLC on Facebook.

About Wright & Schulte LLC
Wright & Schulte LLC, a leading personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Nuvaring Lawsuit Or NuvaRing Blood Clot Lawsuit case evaluations are available through yourlegalhelp.com, or call 1-800-399-0795.

Contact:
Wright & Schulte LLC
"An Experienced Harmful Drug Law Firm"
1-800-399-0795
http://www.yourlegalhelp.com


Contact

Follow us on: Contact's Google Plus